We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DuPont Launches Medical Grade Liquid Silicone Rubber Series
Read MoreHide Full Article
Key Takeaways
DuPont launched the Liveo C6-8XX series of USP Class VI medical-grade, two-part liquid silicone elastomers.
DD says improved rheology and lower viscosity enable faster molding cycles and automated production.
DuPont says the LSR offers heat stability, sterilization options, biocompatibility and 30-70 Shore A range.
DuPont de Nemours, Inc. (DD - Free Report) announced the launch of Liveo C6-8XX Liquid Silicone Rubber (LSR), a new USP Class VI (C6) series of medical-grade, two-part silicone elastomers. These are designed to comply with the stringent requirements of medical device applications.
The rubber series features excellent precision, reliability and processing efficiency for advanced healthcare applications. With improved rheology and lower viscosity, the materials enable faster and more consistent molding cycles while offering higher processing flexibility.
The series is well-suited for fully automated production environments. The new LSR supports development of safe, high-quality, complex medical devices with its high heat stability, multiple sterilization methods and proven biocompatibility. The series has a lineup of five products with varied hardness levels ranging from 30 to 70 Shore A: Liveo C6-830, C6-840, C6-850, C6-860 and C6-870 LSR.
The product meets USP Class VI and select EP regulatory requirements, complying with REACH SVHC regulations and are tested according to ISO 10993 standards. Manufactured under ISO 9001, 14001 and 13485 certifications, the series provides high quality and reliability for healthcare applications. It conveniently comes in two-component kits. Liveo C6-8XX Liquid Silicone Rubber materials complement precision molding and automated systems.
DD stock has lost 38.2% over the past year compared with the industry’s 17.4% decline.
Image Source: Zacks Investment Research
DD’s Zacks Rank & Key Picks
DD currently has a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Coeur Mining, Inc. (CDE - Free Report) , Albemarle Corporation (ALB - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .
The Zacks Consensus Estimate for CDE’s 2025 earnings is pegged at 82 cents per share, indicating a rise of 355.56% year over year. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters while missing it in the remaining two, with an average surprise of 106.61%. CDE’s shares have soared 198.6% over the past year.
The Zacks Consensus Estimate for ALB’s 2025 loss is pinned at $1 per share, indicating a 57.26% year-over-year increase. Its shares have surged 113.5% over the past year.
The Zacks Consensus Estimate for ASM’s 2025 earnings is pinned at 17 cents per share, indicating a 13.33% year-over-year increase. ASM’s shares have skyrocketed 680.5% over the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
DuPont Launches Medical Grade Liquid Silicone Rubber Series
Key Takeaways
DuPont de Nemours, Inc. (DD - Free Report) announced the launch of Liveo C6-8XX Liquid Silicone Rubber (LSR), a new USP Class VI (C6) series of medical-grade, two-part silicone elastomers. These are designed to comply with the stringent requirements of medical device applications.
The rubber series features excellent precision, reliability and processing efficiency for advanced healthcare applications. With improved rheology and lower viscosity, the materials enable faster and more consistent molding cycles while offering higher processing flexibility.
The series is well-suited for fully automated production environments. The new LSR supports development of safe, high-quality, complex medical devices with its high heat stability, multiple sterilization methods and proven biocompatibility. The series has a lineup of five products with varied hardness levels ranging from 30 to 70 Shore A: Liveo C6-830, C6-840, C6-850, C6-860 and C6-870 LSR.
The product meets USP Class VI and select EP regulatory requirements, complying with REACH SVHC regulations and are tested according to ISO 10993 standards. Manufactured under ISO 9001, 14001 and 13485 certifications, the series provides high quality and reliability for healthcare applications. It conveniently comes in two-component kits. Liveo C6-8XX Liquid Silicone Rubber materials complement precision molding and automated systems.
DD stock has lost 38.2% over the past year compared with the industry’s 17.4% decline.
Image Source: Zacks Investment Research
DD’s Zacks Rank & Key Picks
DD currently has a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Coeur Mining, Inc. (CDE - Free Report) , Albemarle Corporation (ALB - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .
While CDE and ALB sport a Zacks Rank #1 (Strong Buy) each at present, ASM carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for CDE’s 2025 earnings is pegged at 82 cents per share, indicating a rise of 355.56% year over year. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters while missing it in the remaining two, with an average surprise of 106.61%. CDE’s shares have soared 198.6% over the past year.
The Zacks Consensus Estimate for ALB’s 2025 loss is pinned at $1 per share, indicating a 57.26% year-over-year increase. Its shares have surged 113.5% over the past year.
The Zacks Consensus Estimate for ASM’s 2025 earnings is pinned at 17 cents per share, indicating a 13.33% year-over-year increase. ASM’s shares have skyrocketed 680.5% over the past year.